Better Access to Liver Cancer Medicines
A Women’s Health Week Guide to Liver Health
Women’s Health Week, from 4th to 8th September, is dedicated to empowering women to take…Read Article
Five health checks to keep your liver healthy in 2023
With the start of a new year, there’s no better time to check in on…Read Article
Better liver health campaign evokes public action against hepatitis
Hepatitis Queensland (HQ) is calling on Queenslanders to come together to eliminate viral hepatitis this…Read Article
Australians living with liver cancer will soon have new treatment options with changes to the Pharmaceutical Benefits Scheme (PBS) coming into effect.
The changes include better access to treatments for patients with advanced unresectable hepatocellular carcinoma. Unresectable hepatocellular carcinoma is the most common form of liver cancer, which often occurs in people with other chronic liver diseases. It also has one of the lowest survival rates of all cancer types.
From 1 November, more than 500 patients per year could benefit from PBS listing of this treatment, which would otherwise cost more than $170,000 per course. Australia will be the first country in the world to have this combination treatment publically funded for this type of liver cancer.